RECURRENT CANCER
Clinical trials for RECURRENT CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CANCER trials appear
Sign up with your email to follow new studies for RECURRENT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists Re-Engineer Patients' own immune cells to fight advanced cancers
Disease control Recruiting nowThis study is testing a new personalized treatment for adults with advanced solid tumors that have returned or stopped responding to standard therapies. Doctors take a patient's own immune cells, modify them in a lab to better target their cancer, and then infuse them back. The t…
Matched conditions: RECURRENT CANCER
Phase: PHASE1, PHASE2 • Sponsor: Immatics US, Inc. • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
New radiation approach tested for Tough-to-Treat gynecologic cancers
Disease control Recruiting nowThis study is testing a specialized radiation technique for patients with cervical cancer or pelvic recurrences who cannot receive standard internal radiation (brachytherapy). The goal is to see if this method can control the cancer in the treated area while limiting damage to ne…
Matched conditions: RECURRENT CANCER
Phase: NA • Sponsor: Tata Memorial Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Custom-Made vaccine trains body to fight its own cancer
Disease control Recruiting nowThis study is testing a personalized cancer vaccine made from the unique mutations found in a patient's own tumor. The goal is to see if this custom vaccine, given with other immune-boosting drugs, is safe and can help control advanced or high-risk cancers. It is for adults with …
Matched conditions: RECURRENT CANCER
Phase: PHASE1, PHASE2 • Sponsor: Seqker Biosciences, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for transplant patients whose liver cancer returns
Disease control Recruiting nowThis study is testing if the drug cabozantinib can help control liver cancer that has come back in people who previously had a liver transplant. The drug works by blocking proteins that help cancer tumors grow. About 20 participants will take the drug until it stops working or si…
Matched conditions: RECURRENT CANCER
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
First patients test new 'T-Cell Engager' drug for Tough-to-Treat cancers
Disease control Recruiting nowThis is the first time a new drug called IMA401 is being tested in people. The main goal is to find a safe dose and see if it can help control advanced solid tumors that have come back or stopped responding to other treatments. The study will test IMA401 by itself and combined wi…
Matched conditions: RECURRENT CANCER
Phase: PHASE1 • Sponsor: Immatics Biotechnologies GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New Triple-Threat attack on tough brain cancer
Disease control Recruiting nowThis study is testing a combination of three drugs (pembrolizumab, ibrutinib, and rituximab) for adults with primary central nervous system lymphoma (PCNSL) that has returned or not responded to prior treatment. The goal is to see if this combination can control the cancer and st…
Matched conditions: RECURRENT CANCER
Phase: PHASE1, PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New 'Double-Target' drug enters human trials for Tough-to-Treat cancers
Disease control Recruiting nowThis trial is testing a new, first-of-its-kind drug called IMA402 in adults with advanced solid tumors that have come back or stopped responding to all standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. The study will enroll about 1…
Matched conditions: RECURRENT CANCER
Phase: PHASE1, PHASE2 • Sponsor: Immatics Biotechnologies GmbH • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for kids with tough cancers: trial matches drugs to Tumor's genetic profile
Disease control Recruiting nowThis trial aims to find better treatments for children and young adults with advanced cancers that have not responded to standard therapies. It will test personalized combinations of targeted drugs, chosen based on the unique genetic profile of each patient's tumor. The goal is t…
Matched conditions: RECURRENT CANCER
Phase: PHASE1, PHASE2 • Sponsor: Australian & New Zealand Children's Haematology/Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC